|
Volumn 10, Issue 3, 2008, Pages 179-
|
The case for dobutamine.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARDIOTONIC AGENT;
DOBUTAMINE;
COST BENEFIT ANALYSIS;
ECONOMICS;
EDITORIAL;
HUMAN;
INTENSIVE CARE;
CARDIOTONIC AGENTS;
COST-BENEFIT ANALYSIS;
CRITICAL CARE;
DOBUTAMINE;
HUMANS;
|
EID: 54849426305
PISSN: 14412772
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (1)
|
References (0)
|